DSCO - There is no way this current management is ever going to get approval from the FDA. The inability of management to realize what the FDA requires after 3 attempts and the fact that the FDA has questions that seem serious enough to delay the launch of this product by a few YEARS due to manufacturing issues, shows the complete incompetence of management. The FDA should be concerned about what would happen to the product even after approval if management is so incompetent. Can they trust management to ensure that the product would be reliable in the future? I think the answer is no. DSCO has to sell itself.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.